共 85 条
[1]
Wiviott SD(2007)Prasugrel versus clopidogrel in patients with acute coronary syndromes N Engl J Med 357 2001-2015
[2]
Braunwald E(2009)Ticagrelor versus clopidogrel in patients with acute coronary syndromes N Engl J Med 361 1045-1057
[3]
McCabe CH(2013)Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis J Thromb Thrombolysis 36 223-232
[4]
Wallentin L(2014)Prasugrel and ticagrelor: is there a winner? J Cardiovasc Med (Hagerstown) 15 8-18
[5]
Becker RC(2014)Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment (ISAR-REACT) 5 Trial Investigators. Randomized comparison of ticagrelor versus prasugrel in patients with acute coronary syndrome and planned invasive strategy--design and rationale of the iNtracoronary stenting and AntithromboticRegimen: rapid early action for coronary treatment (ISAR-REACT) 5 trial J Cardiovasc Transl Res 7 91-100
[6]
Budaj A(2011)Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium Circulation 123 2736-2747
[7]
Chatterjee S(2009)The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcareinterventions: explanation and elaboration BMJ 339 b2700-560
[8]
Ghose A(2003)Measuring inconsistency in meta-analyses BMJ 327 557-343
[9]
Sharma A(2015)Comparison of Ticagrelor versus Prasugrel to prevent Periprocedural Myonecrosis in acute coronary syndromes Am J Cardiol 116 339-278
[10]
Morici N(2014)Ticagrelor versus prasugrel in diabetic patients with an acute coronary syndrome. A pharmacodynamic randomised study Thromb Haemost 111 273-1612